At Evolva, Hansen played a key role in the company’s public listing in 2009 and subsequent public financings. Prior to that, he was CFO of Nuevolution A/S and Zealand Pharma A/S and had senior roles at a Scandinavian investment bank and at Novo Nordisk A/S. 

Hansen succeeds Henrik Moltke, who will gon on to become CFO at Scandinavian Micro Biodevices that was recently acquired by Zoetis.